136 related articles for article (PubMed ID: 32306087)
1. Ofatumumab treatment for nephrotic syndrome recurrence after pediatric renal transplantation.
Bernard J; Lalieve F; Sarlat J; Perrin J; Dehoux L; Boyer O; Godron-Dubrasquet A; Harambat J; Decramer S; Caillez M; Bruel A; Allain-Launay E; Dantal J; Roussey G
Pediatr Nephrol; 2020 Aug; 35(8):1499-1506. PubMed ID: 32306087
[TBL] [Abstract][Full Text] [Related]
2. Ofatumumab in post-transplantation recurrence of a pediatric steroid-resistant idiopathic nephrotic syndrome.
Bernard J; Bruel A; Allain-Launay E; Dantal J; Roussey G
Pediatr Transplant; 2018 Jun; 22(4):e13175. PubMed ID: 29569812
[TBL] [Abstract][Full Text] [Related]
3. Ofatumumab for the treatment of childhood nephrotic syndrome.
Wang CS; Liverman RS; Garro R; George RP; Glumova A; Karp A; Jernigan S; Warshaw B
Pediatr Nephrol; 2017 May; 32(5):835-841. PubMed ID: 28213687
[TBL] [Abstract][Full Text] [Related]
4. Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series.
Podestà MA; Trillini M; Portalupi V; Gennarini A; Tomatis F; Villa A; Perna A; Rubis N; Remuzzi G; Ruggenenti P
Am J Kidney Dis; 2024 Mar; 83(3):340-349.e1. PubMed ID: 37777061
[TBL] [Abstract][Full Text] [Related]
5. Low-dose ofatumumab for multidrug-resistant nephrotic syndrome in children: a randomized placebo-controlled trial.
Ravani P; Pisani I; Bodria M; Caridi G; Degl'Innocenti ML; Ghiggeri GM
Pediatr Nephrol; 2020 Jun; 35(6):997-1003. PubMed ID: 31993781
[TBL] [Abstract][Full Text] [Related]
6. Human or Chimeric Monoclonal Anti-CD20 Antibodies for Children with Nephrotic Syndrome: A Superiority Randomized Trial.
Ravani P; Colucci M; Bruschi M; Vivarelli M; Cioni M; DiDonato A; Cravedi P; Lugani F; Antonini F; Prunotto M; Emma F; Angeletti A; Ghiggeri GM
J Am Soc Nephrol; 2021 Oct; 32(10):2652-2663. PubMed ID: 34544820
[TBL] [Abstract][Full Text] [Related]
7. Ofatumumab in post-transplantation recurrence of focal segmental glomerulosclerosis in a child.
Solomon S; Zolotnitskaya A; Del Rio M
Pediatr Transplant; 2019 Jun; 23(4):e13413. PubMed ID: 30973669
[TBL] [Abstract][Full Text] [Related]
8. Ofatumumab rescue treatment in post-transplant recurrence of focal segmental glomerulosclerosis.
Colucci M; Labbadia R; Vivarelli M; Camassei FD; Emma F; Dello Strologo L
Pediatr Nephrol; 2020 Feb; 35(2):341-345. PubMed ID: 31667616
[TBL] [Abstract][Full Text] [Related]
9. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab.
Vivarelli M; Colucci M; Bonanni A; Verzani M; Serafinelli J; Emma F; Ghiggeri G
Pediatr Nephrol; 2017 Jan; 32(1):181-184. PubMed ID: 27687621
[TBL] [Abstract][Full Text] [Related]
10. Low-dose ofatumumab for rituximab-resistant nephrotic syndrome.
Bonanni A; Rossi R; Murtas C; Ghiggeri GM
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26376698
[TBL] [Abstract][Full Text] [Related]
11. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children.
Salomon R; Gagnadoux MF; Niaudet P
Transplantation; 2003 Mar; 75(6):810-4. PubMed ID: 12660507
[TBL] [Abstract][Full Text] [Related]
12. New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?
Basu B; Angeletti A; Islam B; Ghiggeri GM
Front Immunol; 2022; 13():805697. PubMed ID: 35222385
[TBL] [Abstract][Full Text] [Related]
13. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
[TBL] [Abstract][Full Text] [Related]
14. Rituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome.
Grenda R; Jarmużek W; Rubik J; Piątosa B; Prokurat S
Eur J Pediatr; 2016 Sep; 175(9):1133-1137. PubMed ID: 27364906
[TBL] [Abstract][Full Text] [Related]
15. Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol.
Ravani P; Bonanni A; Ghiggeri GM
BMJ Open; 2017 Mar; 7(3):e013319. PubMed ID: 28314744
[TBL] [Abstract][Full Text] [Related]
16. [NEPHROTIC SYNDROME RECURRENCE POST-RENAL TRANSPLANTATION: 10 YEARS' EXPERIENCE AT SCHNEIDER CHILDREN'S MEDICAL CENTER IN ISRAEL].
Fisher D; Borovitz Y; Alfandari H; LEvi S; Hamdani G; Dagan A; Davidovits M; Landau D; Haskin O
Harefuah; 2021 Dec; 160(12):786-792. PubMed ID: 34957712
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of nephrotic syndrome after renal transplantation: influence of increased immunosuppression.
Nathanson S; Cochat P; André JL; Guyot C; Loirat C; Nivet H; Deschênes G
Pediatr Nephrol; 2005 Dec; 20(12):1801-4. PubMed ID: 16228184
[TBL] [Abstract][Full Text] [Related]
18. UK experience of ofatumumab in recurrence of focal segmental glomerulosclerosis post-kidney transplant.
Reynolds BC; Lamb A; Jones CA; Yadav P; Tyerman KS; Geddes CC
Pediatr Nephrol; 2022 Jan; 37(1):199-207. PubMed ID: 34383125
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T
Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS).
Canaud G; Dion D; Zuber J; Gubler MC; Sberro R; Thervet E; Snanoudj R; Charbit M; Salomon R; Martinez F; Legendre C; Noel LH; Niaudet P
Nephrol Dial Transplant; 2010 Apr; 25(4):1321-8. PubMed ID: 19773419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
